ARBUTUS BIOPHARMA CORP NPV financial statements, including revenue, expenses, profit, and loss
The total revenue of 0SGC for the last quarter is 1.53 M USD, and it's 28.58% lower compared to the previous quarter. The net income of Q1 24 is -17.88 M USD.